文献速递神经MR

扩散峰度成像联合分子标志物综合预测胶质瘤患者总生存期

Diffusion kurtosis imaging combined with molecular markers as a comprehensive approach to predict overall survival in patients with gliomas.
PubMed 文献 · Eur J Radiol · 2020-04-23

研究纳入51例胶质瘤患者,术前3.0 T MRI行常规序列及扩散峰度成像(DKI),测量肿瘤MK、MD、AK、RK值并对侧正常白质归一化,同时免疫组化检测IDH1、ATRX、MGMT。结果显示低MK、AK、RK及高MD患者预后显著更好,IDH1突变、ATRX表达缺失、MGMT阴性表达者生存期更优;Cox多因素分析示MK、RK值及ATRX表达保留为独立预后危险因素,高MK值预后风险最高(HR=65.288)。

要点

  • 低MK、低AK、低RK及高MD的胶质瘤患者总生存期显著更好(P<0.001)。
  • IDH1突变、ATRX表达缺失、MGMT阴性表达者生存期更优(分别P<0.01、P<0.05、P<0.05)。
  • MK、RK值及ATRX表达保留为独立预后危险因素,高MK值风险最高(HR=65.288)。

诊断标准与关键数值

  • 低MK、低AK、低RK及高MD值患者预后显著更好(P<0.001)。
  • IDH1突变患者生存期更优(P<0.01),ATRX表达缺失患者生存期更优(P<0.05),MGMT阴性表达患者生存期更优(P<0.05)。
  • 在IDH1野生型、ATRX表达保留及MGMT阳性表达组中,低MK患者预后更好(P<0.01)。
  • Cox多因素回归显示MK、RK值及ATRX表达保留为独立预后危险因素,高MK值预后风险最高(HR=65.288)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The purpose of this study was to explore the usefulness of diffusion kurtosis imaging (DKI) and molecular markers in predicting the prognosis of glioma patients.

METHOD: Fifty-one patients with gliomas were examined by conventional MRI and DKI at 3.0 T before operation. The mean kurtosis (MK), mean diffusivity (MD), axial kurtosis (AK), and radial kurtosis (RK) values of tumors were measured and normalized to the contralateral normal-appearing white matter. The molecular markers of gliomas, including isocitrate dehydrogenase-1 (IDH1), α thalassemia/mental retardation syndrome x-linked (ATRX) and O6-methylguanine-DNA methyltransferase (MGMT), were immunohistochemically stained on the resected tumor tissues. Statistical methods, including the chi-square test, independent sample t-test, receiver operating characteristic curve analysis, Kaplan-Meier curve analysis, and Cox regression analysis were performed.

RESULTS: The patients with lower MK, AK, RK, and higher MD values showed significantly better prognosis (P < 0.001). Survival time was better in glioma patients with IDH1 mutation (P < 0.01), ATRX loss of expression (P < 0.05), and MGMT negative expression (P < 0.05). However, among the groups of gliomas with IDH1 wild type, ATRX retention and those with MGMT positive expression, the patients with lower MK showed better outcome (P < 0.01). Cox multivariate regression analysis demonstrated that MK, RK values and ATRX retention could be used as independent prognostic risk factors, and high MK values had the highest risk for prognosis (HR = 65.288).

CONCLUSIONS: Molecular markers and DKI parameters, especially MK values, can be used to effectively evaluate the prognosis of glioma patients.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Wang X, Li F, Wang D, et al. Diffusion kurtosis imaging combined with molecular markers as a comprehensive approach to predict overall survival in patients with gliomas. Eur J Radiol. 2020. PMID: 32361603. doi:10.1016/j.ejrad.2020.108985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。